Mieloproliferatív neopláziák: vizsgálatok itt: Hongkong
3 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- 3. fázisFut, nem toborozA Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
- Where
- Hksar
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06351631 · EU 2023-506996-89-00 - 2. fázisTaking peopleRopeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis
- Where
- Hong Kong
- Életkor
- 18 év and over
- People
- 20
- Run by
- The University of Hong Kong
See details and how to joinNCT06770842 - No phaseTaking peopleAsian Myeloproliferative Neoplasm (MPN) Registry
- Where
- Hong Kong
- Életkor
- 18 év and over
- People
- 1000
- Run by
- The University of Hong Kong
See details and how to joinNCT05882773